Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis

Journal of Gastroenterology

Volumn 39, Issue 9, 2004, Pages 859-866

  Tsuchiya, Noriko ^a   Tokushige, Katsutoshi ^a   Yamaguchi, Naoko ^a   Hasegawa, Kiyoshi ^a   Hashimoto, Etsuko ^a   Yamauchi, Katsumi ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Fulminant hepatitis; Polymorphism; TNF

Indexed keywords

ALANINE; CYSTEINE; GENOMIC DNA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SURVIVAL RATE;

ACUTE DISEASE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 6944225278     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1402-1     Document Type: Article

References (29)

1. Muto Y, Nouri-Aria K, Meager A, Alexander G, Eddleston A, Williams R, et al. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988;II:72-4.
2. de la Mata M, Meager A, Roland N, Daniels HM, Nouri-Aria KT, Goka AK, et al. Tumor necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990;82:479-84.
3. Hughes RD, Nicolaou N, Langley PG, Ellis AJ, Wenden JA, Williams R. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif Organs 1998;22:854-8.
4. Sekiyama KD, Yoshiba M, Thomson W. Circulating proinflammatory cytokines (IL1-β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant failure and acute hepatitis. Clin Exp Immunol 1994;98:71-7.
5. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N. Significance of soluble TNF receptor-1 in acute-type fulminant hepatitis. Am J Gastroenterol 2000;95:2040-6.
6. Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, Manus M, et al. Concanavalin A-induced liver cell damage. Activation of intracellular pathway triggered by tumor necrosis factor in mice. Gastroenterology 1998;114:1035-45.
7. Wilson AG, de Giovine FS, Duff GW. Genetics of TNFα in autoimmune, infectious and neoplastic diseases. J Inflamm 1995; 45:1-12.
8. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility alleles with the secretion of TNF alpha and TNF beta by human mononuclear cells; a possible link to insulin dependent diabetes mellitus. Eur J Immunol 1993;23:224-31.
9. McGuire W, Hill AVS, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
10. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999;179:287-90.
11. Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;117:1062-8.
12. Wilson AG, Symons JA, McDowell TL, McDevitt HD, Duff GW. Effect of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-9.
13. Takahashi Y, Shimizu M. The study group of fulminant hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicenter study. J Gastroenterol Hepatol 1991;6:159-64.
14. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis. Hepatology 1996;23:389-95.
15. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus by two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-22.
16. Kaneshige T, Takagi K, Nakamura S, Hirasawa T, Sada M, Uchida K. Genetic analysis using fingernail DNA. Nucleic Acids Res 1992;20:5489-90.
17. Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J Hepatol 1998;29:53-9.
18. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha gene detectable by Nco1 restriction of PCR product. Hum Mol Genet 1992;1:353.
19. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff Gw, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumor necrosis factor alpha promoter region. J Hepatol 1999;31:242-7.
20. Yee LJ, Tang J, Herrera J, Kaslow RA, Leeuwen DJ. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 2000;1: 386-90.
21. Tokushige K, Tsuchiya N, Hasegawa K, Hashimoto E, Yamauchi K, Komatsu T, et al. Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV. Am J Gastroenterol 2003;98:160-6.
22. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998; 51:605-12.
23. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-4.
24. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991;324:1705-9.
25. Hasegawa K, Huang J, Rogers SA, Blum HE, Liang TJ. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994;68:1651-9.
26. Fujiwara K, Yokosuka O, Imazeki F, Saisho H, Saotome N, Suzuki K, et al. Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities. Hepatol Res 2003;25:124-34.
27. Joh R, Hasegawa K, Ogawa M, Ishikawa K, Iizuka A, Naritomi T, et al. Genotypic analysis of hepatitis B virus from patients with fulminant hepatitis: comparison with acute self-limited hepatitis. Hepatol Res 2003;26:119-24.
28. Yoshiba M, Dehara K, Inoue K, Okamoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 1994;19:829-35.
29. Yoshiba M, Sekiyama K, Inoue K, Yamada M, Kako M, Nagai K, et al. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study. J Gastroenterol 2002;37: 916-21.